These findings show that apigenin can alter TNF-α mediated breast cancer signaling pathways that control the release of CCL2, which in part involve IKBK-epsilon, and ERK, both essential biological events required for TAM infiltration and recruitment into solid breast tumor tissue. The gene discussed is TNF; the disease is breast cancer.